Prediction of Arrhythmic Events with Positron Emission Tomography: PAREPET study design and methods

Contemporary Clinical Trials

Volumn 27, Issue 4, 2006, Pages 374-388

  Fallavollita, James A ^a,b,c   Luisi Jr , Andrew J ^b,c   Michalek, Suzanne M ^b   Valverde, Arturo M ^a,b,c   deKemp, Robert A ^d   Haka, Michael S ^b   Hutson, Alan D ^b   Canty Jr , John M ^a,b,c  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

11C meta hydroxyephedrine; 13N ammonia; 18F 2 deoxyglucose; Hibernating myocardium; Positron emission tomography; Sudden cardiac death; Sympathetic nerves; Viable myocardium

Indexed keywords

3 HYDROXYEPHEDRINE C 13; AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; NORADRENALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CARDIAC PATIENT; CLINICAL TRIAL; COHORT ANALYSIS; DEFIBRILLATOR; FOLLOW UP; GLUCOSE CLAMP TECHNIQUE; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MORTALITY; NORADRENALIN UPTAKE; OBSERVATIONAL STUDY; PATIENT IDENTIFICATION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SYMPATHETIC INNERVATION; TELEPHONE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; FOLLOW-UP STUDIES; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33746950472     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.03.005     Document Type: Article

References (103)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Curtis J.P., Sokol S.I., Wang Y., et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 42 (2003) 736-742
4. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 (2001) 1473-1482
5. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
6. Daubert J.P., Zareba W., Schuger C.D., et al. Does EPS inducibility in MADIT II patients predict subsequent VT and/or VF events?. Pacing Clin Electrophysiol 26 4 Pt II (2003) 960
7. Buxton A.E. Identifying the high risk patient with coronary artery disease-is ejection fraction all you need?. J Cardiovasc Electrophysiol 16 Suppl 1 (2005) S25-S27
8. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119 (1993) 1187-1197
9. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
10. Canty Jr. J.M., and Fallavollita J.A. Chronic hibernation and chronic stunning: a continuum. J Nucl Cardiol 7 (2000) 509-527
11. Canty J.M., and Fallavollita J.A. Hibernating myocardium. J Nucl Cardiol 12 (2005) 104-119
12. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
13. Miller W.L., Tointon S.K., Hodge D.O., et al. Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects. Am Heart J 143 (2002) 904-909
14. Schelbert H.R., Beanlands R., Bengel F., et al. PET myocardial perfusion and glucose metabolism imaging: part 2-guidelines for interpretation and reporting. J Nucl Cardiol 10 (2003) 557-571
15. Podio V., Spinnler M.T., Bertuccio G., et al. Prognosis of hibernating myocardium is independent of recovery of function: evidence from a routine based follow-up study. Nucl Med Commun 23 (2002) 933-942
16. Zipes D.P. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82 (1990) 1095-1105
17. Wakabayashi T., Nakata T., Hashimoto A., et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 42 (2001) 1757-1767
18. Pietila M., Malminiemi K., Ukkonen H., et al. Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 28 (2001) 373-376
19. Martins J.B., and Zipes D.P. Epicardial phenol interrupts refractory period responses to sympathetic but not vagal stimulation in canine left ventricular epicardium and endocardium. Circ Res 40 (1980) 33-40
20. Barber M.J., Mueller T.M., Henry D.P., Felten S.Y., and Zipes D.P. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67 (1983) 787-796
21. Calkins H., Lehmann M.H., Allman K., Wieland D., and Schwaiger M. Scintigraphic pattern of regional cardiac sympathetic innervation in patients with familial long QT syndrome using positron emission tomography. Circulation 87 (1993) 1616-1621
22. Inoue H., and Zipes D.P. Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart. Circ Res 62 (1988) 1111-1120
23. Lotze U., Kaepplinger S., Kober A., et al. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. J Nucl Med 42 (2001) 49-54
24. Hartikainen J., Mustonen J., Kuikka J., Vanninen E., and Kettunen R. Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction. Am J Cardiol 80 (1997) 273-277
25. Bulow H.P., Stahl F., Lauer B., et al. Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun 24 (2003) 233-239
26. Luisi Jr. A.J., Fallavollita J.A., Suzuki G., and Canty Jr. J.M. Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium. Circulation 106 (2002) 779-781
27. 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med 46 (2005) 1368-1374
28. Canty Jr. J.M., Suzuki G., Banas M.D., et al. Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death. Circ Res 94 (2004) 1142-1149
29. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverterdefibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
30. Veenhuyzen G.D., Singh S.N., McAreavey D., Shelton B.J., and Exner D.V. Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction. Circulation 104 (2001) 1489-1493
31. Bigger Jr. J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337 (1997) 1569-1575
32. Haas F., Augustin N., Holper K., et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol 36 (2000) 1927-1934
33. Bax J.J., Visser F.C., Poldermans D., et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 104 (2001) I-314-I-318
34. Tseng H., Link J.M., Stratton J.R., and Caldwell J.H. Cardiac receptor physiology and its application to clinical imaging: present and future. J Nucl Cardiol 8 (2001) 390-409
35. Anonymous. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 68 (1983) 939-950
36. Di Carli M.F., Davidson M., Little R., et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73 (1994) 527-533
37. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularizaiton. Circulation 90 (1994) 2687-2694
38. Eitzman D., Al-Aouar Z., Kanter H.L., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20 (1992) 559-565
39. Chaudhry F.A., Tauke J.T., Alessandrini R.S., et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 34 (1999) 730-738
40. Afridi I., Grayburn P.A., Panza J.A., et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 32 (1998) 921-926
41. Pasquet A., Robert A., D'Hondt A.M., et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 100 (1999) 141-148
42. Smart S.C., Dionisopoulos P.N., Knickelbine T.A., Schuchard T., and Sagar K.B. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction. J Am Coll Cardiol 33 (1999) 512-521
43. Anselmi M., Golia G., Cicoira M., et al. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 81 (1998) 21G-28G
44. Senior R., Kaul S., and Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 33 (1999) 1848-1854
45. Gioia G., Milan E., Giubbini R., et al. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 3 (1996) 150-156
46. Gioia G., Powers J., Heo J., and Iskandrian A.S. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 75 (1995) 759-762
47. vom Dahl J., Altehoefer C., Sheehan F.H., et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 38 (1997) 742-748
48. Thomas S.A., Fallavollita J.A., Borgers M., and Canty Jr. J.M. Dissociation of regional adaptations to ischemia and global myolysis in an accelerated swine model of chronic hibernating myocardium. Circ Res 91 (2002) 970-977
49. Canty Jr. J.M., and Fallavollita J.A. Lessons from experimental models of hibernating myocardium. Coron Artery Dis 12 (2001) 371-380
50. Fallavollita J.A., and Canty Jr. J.M. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation 99 (1999) 2798-2805
51. Canty Jr. J.M., and Fallavollita J.A. Resting myocardial flow in hibernating myocardium: validating animal models of human pathophysiology. Am J Physiol 277 (1999) H417-H422
52. Fallavollita J.A., Perry B.J., and Canty Jr. J.M. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium: evidence for transmural variations in chronic hibernating myocardium. Circulation 95 (1997) 1900-1909
53. Melon P.G., de sheere C.M., Degueldre C., et al. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. J Am Coll Cardiol 30 (1997) 1651-1659
54. Sawada S., Elsner G., Segar D.S., et al. Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium. J Am Coll Cardiol 29 (1997) 55-61
55. Fallavollita J.A., Malm B.J., and Canty Jr. J.M. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 92 (2003) 48-55
56. Fallavollita J.A., Logue M., and Canty Jr. J.M. Coronary patency and its relation to contractile reserve in hibernating myocardium. Cardiovasc Res 55 (2002) 131-140
57. Malm B.J., Suzuki G., Canty Jr. J.M., and Fallavollita J.A. Variability of contractile reserve in hibernating myocardium: dependence on the method of stimulation. Cardiovasc Res 56 (2002) 422-433
58. Fallavollita J.A., Lim H., and Canty Jr. J.M. Apoptosis and reduced SR gene expression precede the transition from chronically stunned to hibernating myocardium. J Mol Cell Cardiol 33 (2001) 1937-1944
59. Lim H., Fallavollita J.A., and Canty Jr. J.M. Myocyte apoptosis and regional myocyte loss are inversely related to the duration of hibernating myocardium. Circulation 104 (2001) II-162-II-163
60. Fallavollita J.A., Jacob S.C., Young R.F., and Canty Jr. J.M. Regional alterations in SR Ca2+ ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol 277 (1999) H1418-H1428
61. Di Carli M.F., Maddahi J., Rokhsar S., et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 116 (1998) 997-1004
62. Greenberg H.M., Case R.B., Brown M.W., Carroll E.R., and Moss A.J. Mechanisms of mortality in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). Pacing Clin Electrophysiol 26 4 Pt II (2003) 961
63. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
64. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
65. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
66. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
67. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
68. Fallen E.L., Coates G., Nahmias C., et al. Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction. Am Heart J 137 (1999) 863-869
69. Allman K.C., Wieland D.M., Muzik O., et al. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 22 (1993) 368-375
70. Luisi Jr. A.J., Canty Jr. J.M., deKemp R.A., et al. Patients with ischemic cardiomyopathy eligible for ICD therapy demonstrate extensive sympathetic denervation out of proportion to previous infarction. Circulation 112 Suppl II (2005) II-472
71. Bulow H., Stahl F., Lauer B., et al. Myocardial presynaptic sympathetic innervation evaluated with 11C-HED-PET in patients with severe coronary artery disease but no history of myocardial infarction. J Nucl Med 43 Suppl (2002) 184 p
72. Madsen B.K., Rasmussen V., and Hansen J.F. Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 58 (1997) 151-162
73. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
74. Tapanainen J.M., Lindgren K.S., Makikallio T.H., et al. Natriuretic peptides as predictors of nonsudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 43 (2004) 757-763
75. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
76. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
77. Gottdiener J.S., Bednarz J., Devereux R., et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17 (2004) 1086-1119
78. Choi Y., Huang S.C., Hawkins R.A., et al. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med 40 (1999) 1045-1055
79. Schafers M., Dutka D., Rhodes C.G., et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 82 (1998) 57-62
80. Luisi Jr. A.J., Fallavollita J.A., Toorongian S.A., et al. 11C-hydroxyephedrine PET of hibernating myocardium demonstrates extensive sympathetic denervation. Circulation 106 Suppl II (2002) II-387
81. Bacharach S.L., Bax J.J., Case J., et al. PET myocardial glucose metabolism and perfusion imaging: part 1-guidelines for data acquisition and patient preparation. J Nucl Cardiol 10 (2003) 543-556
82. Hamacher K., Coenen H.H., and Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27 (1986) 235-238
83. Wieland B., Bida G., Padgett H., et al. In-target production of [13N]ammonia via proton irradiation of dilute aqueous ethanol and acetic acid mixtures. Int J Rad Appl Instrum [A] 42 (1991) 1095-1098
84. Rosenspire K.C., Haka M.S., Van Dort M.E., et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 31 (1990) 1328-1334
85. Hinkle Jr. L.E., and Thaler H.T. Clinical classification of cardiac deaths. Circulation 65 (1982) 457-464
86. Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 342 (2000) 1937-1945
87. Raitt M.H., Klein R.C., Wyse D.G., et al. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol 91 (2003) 812-816
88. Daubert J.P., Wilber D.J., Lin A., et al. ICD therapy for fast ventricular tachycardia or ventricular fibrillation is a surrogate endpoint for mortality in MADIT II. Circulation 108 (2003) IV-385
89. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110 (2004) 3760-3765
90. de Milliano P.A.R., de Groot A.C., Tijssen J.G.P., et al. Beneficial effects of metoprolol on myocardial sympathetic function: evidence from a randomized, placebo-controlled study in patients with congestive heart failure. Am Heart J 144 (2002) E3
91. Stevens M.J., Dayanikli F., Raffel D.M., et al. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 31 (1998) 1575-1584
92. Cupples L.A., Gagnon D.R., and Kannel W.B. Long- and short-term risk of sudden coronary death. Circulation 85 (1992) I11-I18
93. Schonfeld D. Partial residuals for the proportional hazards model. Biometrika 69 (1982) 51-55
94. deKemp R.A., and Nahmias C. Automated determination of the left ventricular long axis in cardiac positron tomography. Physiol Meas 17 (1996) 95-108
95. Laubenbacher C., Rothley J., Sitomer J., et al. An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med 34 (1993) 968-978
96. Rosenspire K.C., Schwaiger M., Mangner T.J., et al. Metabolic fate of 13N-ammonia in human and canine blood. J Nucl Med 31 (1990) 163-167
97. Tawakol A., Skopicki H.A., Abraham S.A., et al. Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy. J Am Coll Cardiol 36 (2000) 2146-2153
98. Patlak C.S., and Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multipletime uptake data. Generalizations. J Cereb Blood Flow Metab 5 (1985) 584-590
99. Ratib O., Phelps M.E., Huang S.-C., et al. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 23 (1982) 577-586
100. Di Carli M.F., Tobes M.C., Mangner T., et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 336 (1997) 1208-1215
101. Beanlands R.S., Ruddy T.D., deKemp R.A., et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 40 (2002) 1735-1743
102. Auerbach M.A., Schoder H., Hoh C., et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 99 (1999) 2921-2926
103. Bax J.J., Cornel J.H., Visser F.C., et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 30 (1997) 377-383